Primary Open-Angle Glaucoma (POAG): Clinical Trials

5 trials for Primary Open-Angle Glaucoma (POAG), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Terminated 1
Phase 12Recruiting 1, Terminated 1

Follow Primary Open-Angle Glaucoma (POAG): new trials by email Literature Review of Primary Open-Angle Glaucoma (POAG) trials Research Report on Primary Open-Angle Glaucoma (POAG)

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
GVB-2001-high dose, GVB-2001-low dose - Primary Open-Angle Glaucoma (POAG)
Phase 1 / Phase 2RecruitingIVIEW Therapeutics Inc.62025-11-192026-05-04
Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
Mexidol, Placebo - Primary Open-Angle Glaucoma (POAG)
Phase 2CompletedPharmasoft1022021-11-152025-12-12
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
trabodenoson 6.0% / latanoprost 0.005% QD, trabodenoson 3.0% / latanoprost 0.005% QD, trabodenoson 6.0% / latanoprost 0.0025% QD - Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Phase 2CompletedInotek Pharmaceuticals Corporation2012016-08-192018-02-15
Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension
DWT device dose A, Ellex Tango SLT machine, DWT device dose B - Primary Open-angle Glaucoma (POAG), Ocular Hypertension (OHT)
Phase 1 / Phase 2TerminatedOcuTherix, Inc.352013-11-012017-04-04
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Trabodenoson, Latanoprost, Timolol - Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Phase 2CompletedInotek Pharmaceuticals Corporation1012013-08-012017-12-02

Narrower conditions

Glaucoma (5)  ·  Glaucoma, Open-Angle (5)  ·  Ocular Hypertension (3)  ·  Mitochondrial Diseases (1)  ·  Night Blindness, Congenital Stationary, Autosomal Dominant 1 (1)

Broader conditions

Eye Diseases (5)  ·  Ocular Hypertension (2)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Latanoprost (2)  ·  trabodenoson (2)  ·  INO-8875 (1)  ·  Timolol (1)  ·  emoxypine succinate (1)  ·  ethylmethylhydroxypyridine succinate (1)

Sponsors

Inotek Pharmaceuticals Corporation (2)  ·  IVIEW Therapeutics Inc. (1)  ·  OcuTherix, Inc. (1)  ·  Pharmasoft (1)

Countries

United States (2)  ·  China (1)  ·  Philippines (1)  ·  Russia (1)

Top investigators

Cadmus C Rich, MD,MBA,CPE (1)  ·  Edgar U. Leuenberger, MD (1)  ·  Harvey Siy Uy, MD (1)  ·  Maria I Yap-Veloso, MD (1)  ·  Peirong Lu, MD (1)